GenomeUp is a precision medical Saas, it allows doctors to fully exploit the potential of Artficial Intelligence (AI). Doctors get a detailed clinical report on genes affecting patients’ pathologies, the gravity of the new selected mutations and the last personalized therapies, mining the information from the world’s biggest biomedical database PubMed, on the basis of patients’ genetic data. Integrating the genome knowledge and the translational medicine GenomeUp aims to improve patients’ treatments through the latest computer technologies.
B2C, B2B
1 to 25
Pre-Seed
€630K
Scaling Up
2017
Managed Health Care
Health Care Facilities & Hospitals
Computer Software
Biotechnology
GenomeUp was born to analyze genomic data using in
Increase Efficiency
Analytics
IT and Security
Service
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
Automated Planning and Search
Software
N/A
5
1
$1.2M
Company was founded 2017 and it took almost 5 years (Feb 2022) to raise first external round
Investors
Interested in researching GenomeUp?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about GenomeUp
Simone Gardini
Co-Founder & CEO
Giovanni Stracquadaneo
COO
Nicolò Risitano
CTO
Nicolo Risitano
Chief Technology Officer
Potential Customers
Interested in what they do or partnership?
Learn more about how they work
